Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2017-09-05 Regulatory Filings
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Extension of a 5 year contract
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 05 September 2017. The content announces a business development: the 'Extension of a 5 year contract in a Phase II/III Alzheimer's Disease clinical trial' with a value increase. This is a typical announcement of a significant business event or contract update, not a formal financial report (like 10-K or IR) or a transcript. Since it is a general announcement disseminated via the RNS system and concerns a material business event that doesn't fit perfectly into CAP (Capital/Financing), LTR (Legal), or DIV (Dividend), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly labeled as an RNS filing.
2017-09-05 English
Director/PDMR Shareholding
Remuneration Information Classification · 1% confidence The document is identified by the 'RNS Number : 4442N' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content details the 'Share option grant' to the CFO, Susan Lowther, including the number of options granted and her resulting total holding. This type of announcement, detailing personal share transactions or option grants for directors/executives, falls under the category of Director's Dealing (DIRS). Although it involves options, the primary focus is the insider transaction disclosure, which is more specific than a general Capital/Financing Update (CAP) or a general Regulatory Filing (RNS). Given the specific mention of a Director's option grant, DIRS is the most appropriate classification.
2017-08-08 English
Expansion of Collaboration with Biogen
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement from the London Stock Exchange's news service. The content describes a business development: the expansion of a commercial collaboration and pilot program for the Assessa® PML platform involving IXICO and Biogen, including financial details related to the project. This is a material announcement regarding business operations and potential revenue, but it is not a full financial report (10-K, IR), a transcript (CT), or a formal dividend/share change notice. Since it is a general, material announcement distributed via the RNS system and doesn't fit the more specific categories like ER, DIV, or CAP, the most appropriate classification is the general Regulatory Filings category (RNS). The document length (5692 chars) is substantial enough that it is the announcement itself, not just a brief notice pointing to a larger document.
2017-07-24 English
IXICO hosts Alzheimer Expert Symposium
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content describes a specific, non-periodic corporate event: IXICO hosting an 'Alzheimer Expert Symposium' coinciding with a major conference. This is a general corporate announcement disseminated via the Regulatory News Service (RNS) that does not fit into specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Therefore, the most appropriate classification is the general regulatory announcement fallback category.
2017-07-18 English
New contract for imaging clinical trial services
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated '05 July 2017'. The content announces a significant business event: signing a new contract for specialist imaging clinical trial services. This type of announcement, which details operational news, contract wins, or business updates that are not strictly financial results (ER), management changes (MANG), or director dealings (DIRS), is typically disseminated via regulatory news services. Since it is a specific business update disseminated through the RNS system and does not fit precisely into the other defined categories (like 10-K, ER, or DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2017-07-05 English
Half Yearly Report to 31 March 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half Yearly Report' for IXICO plc for the period ended 31 March 2017. It contains comprehensive financial statements, including a Consolidated Statement of Comprehensive Income, and detailed management commentary on financial performance, operational highlights, and business outlook. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2017
2017-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.